Claim vs Reality
“Leronlimab patents are owned by
Claim vs Reality
“Leronlimab patents are owned by Progenics & AbbVie, not CYDY”
❌ Misleading—Progenics licensed it to CYDY in 2012; AbbVie has no involvement
Leronlimab is “nothing special”
❌ False—CCR5 targeting mAb with unique safety and multi-indication potential
Progenics tried to sell it and failed
❌ False—they licensed it and moved on; no evidence of attempted sale
CYDY couldn’t get a partner
⚠️ Partly true—but due to management/regulatory issues, not lack of drug value
I believe your statements about Leronlimab and CytoDyn are inaccurate and misleading. Leronlimab is not “owned” by AbbVie or Progenics—Progenics licensed the rights to CytoDyn in 2012, and AbbVie has no known involvement. It’s also misleading to say the drug is “nothing special,” as Leronlimab is a CCR5-targeting monoclonal antibody with demonstrated promise in HIV, cancer, and other conditions, supported by clinical data and a strong safety profile. Progenics did not try to sell the drug for years—they licensed it, which is common in biotech, and moved on to other priorities. While CytoDyn has certainly struggled with leadership and regulatory issues, that doesn’t equate to the science being invalid. If your intention is to share honest concerns, that’s fair—but if you’re pushing a narrative built on outdated or false assumptions, it does a disservice to others doing real due diligence.
6
CytoDyn Inc (CYDY) Stock Research Links
LETS GO!!!
Scroll down for more posts ▼
Top 10 Most Recent News Articles
BlueCollar Cloud Aligns with SuiteWorld 2026 If you thought the construction ERP space was just a dusty office in a backlot, think again. BlueCollar Cloud is strapping on its boots and diving into the heart of SuiteWorld 2026 with a platinum sponsorship. This isn't just a walk in the park—it's a strategic power move, aligning themselves smack-dab in the middle of...
Continue Reading
Revolutionizing the E-Commerce Landscape Wake up and smell the innovation, folks! SureDone is rolling out Taska AI, a tool that's set to declutter the chaotic world of enterprise marketplace listings. It's no bed of roses for sellers out there, dealing with diverse channel demands and post-submission hiccups. Taska AI steps in as the seasoned handyman these sellers...
Continue Reading
Oracle Steps into Healthcare's Payment Arena You ever try solving a puzzle with half the pieces missing? Well, that's exactly what healthcare orgs have been doing with their revenue cycles. Oracle (NYSE:ORCL) thinks it’s got the missing pieces. They've announced some slick AI capabilities to grease the wheels of healthcare revenue management. But hey, I've seen grand...
Continue Reading
Something's Buzzing at the Big Board Walk over to Wall Street on September 23rd, and guess what you get? A lot more than just stock tickers blinking away. First Lady Melania Trump’s stealing the show at the New York Stock Exchange to kick off the inaugural IMPERIA Summit. She’s there to sound the opening bell and lead the charge in a summit that's focused on the...
Continue Reading
Straight outta Burlington, the M&T Bank Vermont City Marathon is giving its course a facelift and, get this, throwing a half marathon into the mix for 2027. It's about time they shook things up, considering how this race is supposed to be one of the most welcoming on the block. I mean, you're talking about a marathon that's practically been the crown jewel of Vermont's...
Continue Reading
Rethinking Beauty Industry's AI Obsession Here’s a breath of fresh air from the otherwise AI-obsessed beauty landscape: SACHEU, the brand that's been turning heads in cosmetics, decided to pair up with Limitless Labs. This partnership isn't about ceding control to machines but amplifying genuine human voices in their product development process. Yeah, it's a...
Continue Reading
Change Is Afoot at Riverside Theatre Down in Vero Beach, amid the sun-drenched coziness of Florida’s Treasure Coast, something’s cooking that has nothing to do with sunshine: Riverside Theatre snagged itself a new Chief Financial Officer. As nonprofits go, this one’s not a backyard operation—it’s the largest independent professional theatre in the entire state....
Continue Reading
Legal Maneuver Against Lincoln Educational Services Here we go again—another day, another lawsuit. The recent flap with Lincoln Educational Services Corporation (NASDAQ: LINC) is as classic as any market rug pull. Stepping into the spotlight, Wolf Haldenstein Adler Freeman & Herz LLP—a courtroom icon since 1888—has announced a class action lawsuit against Lincoln....
Continue Reading
Navigating the healthcare maze isn't for the faint of heart, especially when it comes to making sure that dollars spent on food benefits actually translate to improved health. Enter Foodsmart, the foodcare powerhouse that just rolled out its Food-is-Medicine Benefits Management (FBM) program. Turning Meals into Measurable Metrics Health plans are under mounting pressure...
Continue Reading
Epiclay™ Brings New Energy to Sculpting World Folks, if ever there was a time to break the mold, it’s now, and Ace of Clay’s got us covered with Epiclay™—a fresh take on polymer clay that’s turning heads in the sculpture circuit. Over four long years, Ace of Clay, a brand that's gathered a rather colorful following through captivating sculptures and detailed...
Continue Reading
Top 5 Most Recently Viewed Articles
Alan McKim's Important Insider Transaction On a recent day of trading, ALAN MCKIM, Executive Chair at Clean Harbors, executed a significant sale of shares, amounting to $11.14 million. This insider transaction was disclosed in a Form 4 filing with the SEC, revealing the sale of 52,999 shares of the company. Understanding the implications of such a transaction can be...
Continue Reading
What's Up with York Space Systems? Alright, let's dive straight into this unfolding drama. York Space Systems—fresh off their IPO in January 2026—is now neck-deep in a class action lawsuit courtesy of Robbins LLP. It's a heavy hitter for folks who put money into their stock under the assumption that it was as solid as a rock. Instead, there seems to be a soft...
Continue Reading
Boeing Agrees to Plead Guilty to Fraud Conspiracy Charge Boeing has consented to enter a guilty plea to a criminal fraud conspiracy allegation. Part of a settlement with the U.S. Justice Department is this plea. The matter pertains to the two fatal 737 MAX tragedies in Ethiopia and Indonesia. These fell between 2018 and 2019. There were 349 fatalities among the crashes....
Continue Reading
Growth Projections in the Pancreatic Cancer Treatment Market The pancreatic cancer treatment market is on a significant upward trajectory, with projections indicating it could reach an impressive USD 10.2 billion by 2034. This anticipated growth is fueled by groundbreaking advancements in immunotherapies, targeted therapies, and early diagnostic technologies, boasting a...
Continue Reading
Bancography Introduces Branch Closure Analysis Tool Bancography, a prominent financial services consulting firm, has recently launched a groundbreaking feature within its Bancography Plan that focuses on forecasting the impact of potential branch closures. This innovative addition allows banks and credit unions to make informed decisions based on robust data rather than...
Continue Reading